Delivery Order SPE2DB20D3304-SPE2DB26FW4H0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $129,776.48 to AmerisourceBergen Drug Corp for the supply of 60-tablet packages of Eliquis 5 mg tablets under a firm fixed-price contract. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $17,919.22 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 13, 2025, with completion expected by September 15, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,601.44 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a $6,744.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 10, 2025. This competitive award, issued on September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains operations as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $17,221.27 to AmerisourceBergen Drug Corp for 60-count packages of Eliquis 5 mg tablets, with an ultimate completion date of October 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a $7,685.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of June 3, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under AmerisourceBergen's broader federal contracting relationship with DLA. The order will be fulfilled from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,036.99 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 26, 2025, with completion expected by August 27, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement supporting federal medical supply needs for military and veteran healthcare systems through the DLA's established...
- The Defense Logistics Agency awarded a delivery order valued at $72,449.45 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 19, 2025. This competitive award, issued without a set-aside designation, carries a firm fixed price and an ultimate completion date of September 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB26FW4H0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,733.67 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on October 27, 2025, with a completion date of October 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense Health System's pharmaceutical supply chain, distributing both brand-name and generic medications to support military and veteran healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies to support worldwide military healthcare programs. The IDC enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning AmerisourceBergen as a key participant in the DLA's pharmaceutical supply infrastructure for government medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 10/27/25 |